Holen Sie sich die Stockscreener-App
14.60
3.69%
-0.56
Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten
Why Arcus Biosciences Inc. stock is rated strong buy2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com
Arcus Biosciences (RCUS) Reveals Promising Phase 2 Gastric Cance - GuruFocus
Arcus Biosciences Turns Heads With 26.7-Month Survival In Gastric Cancer Study — Retail Calls It ‘Unprecedented’ - Stocktwits
Arcus Biosciences to present promising gastric cancer survival data - Investing.com
Arcus Biosciences Shows 26.7‑Month Median OS in EDGE‑Gastric | RCUS Stock News - Stock Titan
Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Price momentum metrics for Arcus Biosciences Inc. explainedWeekly Trend Summary & AI Driven Price Predictions - newser.com
Arcus Biosciences (NYSE:RCUS) COO Jennifer Jarrett Sells 37,792 Shares of Stock - MarketBeat
60,300 Options at $15.05 — Arcus Biosciences Grants 30,150 RSUs under 2020 Inducement Plan - Stock Titan
Arcus Biosciences Hits Day High with Strong 7.27% Intraday Surge - Markets Mojo
Arcus Biosciences Hits Day High with Strong 8.46% Intraday Surge - Markets Mojo
Arcus Biosciences’ SWOT analysis: oncology firm’s stock faces pivotal data By Investing.com - Investing.com Australia
Arcus Biosciences COO Jarrett sells $750k in shares By Investing.com - Investing.com Canada
Arcus Biosciences’ SWOT analysis: oncology firm’s stock faces pivotal data - Investing.com India
Arcus Biosciences (RCUS) Soars 8.5%: Is Further Upside Left in the Stock? - MSN
Weiss Ratings Reaffirms "Sell (D-)" Rating for Arcus Biosciences (NYSE:RCUS) - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Arcus Biosciences stock By Investing.com - Investing.com Canada
RCUS: Truist Securities Raises Price Target for Arcus Biosciences | RCUS Stock News - GuruFocus
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment - inkl
A Fresh Look at Arcus Biosciences (RCUS) Valuation After New Casdatifan Data and Expanded Pipeline Initiatives - Yahoo Finance
Arcus Biosciences announces new anti-inflammation programs - BioWorld MedTech
Truist Raises Price Target on Arcus Biosciences to $39 From $32, Keeps Buy Rating - MarketScreener
Arcus Biosciences Presents Promising ARC-20 Study Data - MSN
Why Is Arcus Biosciences Stock Trading Higher On Monday? - Sahm
Arcus Biosciences (NYSE:RCUS) Trading Up 15.2%Here's What Happened - MarketBeat
Transcript : Arcus Biosciences, Inc.Shareholder/Analyst Call - MarketScreener
Arcus Biosciences (RCUS) Sees Promising Results in Latest Study - GuruFocus
Arcus Biosciences (RCUS) Shares Positive Data on Casdatifan for Metastatic RCC - GuruFocus
Arcus Biosciences presents new data for its HIF-2a inhibitor casdatifan - MarketScreener
Arcus Biosciences reports positive casdatifan data, expands into inflammation - StreetInsider
Can momentum traders help lift Arcus Biosciences Inc.Weekly Stock Recap & Weekly High Return Forecasts - newser.com
What drives Arcus Biosciences Inc stock priceSector Performance Drivers & Free Superior Stock Performance - earlytimes.in
How to use Fibonacci retracement on Arcus Biosciences Inc.Trade Analysis Summary & Safe Capital Allocation Plans - newser.com
Published on: 2025-10-05 02:17:26 - newser.com
Pleasing Signs As A Number Of Insiders Buy Arcus Biosciences Stock - simplywall.st
Technical analysis overview for Arcus Biosciences Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Arcus Biosciences, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Arcus Biosciences Hits Day High with 9.94% Surge in Strong Intraday Performance - Markets Mojo
Barclays Keeps Their Buy Rating on Arcus Biosciences (RCUS) - The Globe and Mail
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Arcus Biosciences (NYSE:RCUS) CAO Alexander Azoy Sells 2,831 Shares - MarketBeat
Published on: 2025-09-30 20:31:22 - newser.com
Insider Sell: Alexander Azoy Sells Shares of Arcus Biosciences I - GuruFocus
What analysts say about Arcus Biosciences Inc stockIndustrial Stocks Review & Big Profit Small Investment - earlytimes.in
Arcus Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Arcus Biosciences Inc Stock Analysis and ForecastMarket Rumors and News & Affordable Investment Strategies - earlytimes.in
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):